Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bardet-Biedl Syndrome”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Very early researchLooking for participantsNCT07269665
What this trial is testing

First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration

Who this might be right for
Bardet-Biedl Syndrome 1Retinal Degeneration
Axovia Therapeutics 12
Not applicableStudy completedNCT04874909
What this trial is testing

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

Who this might be right for
CiliopathiesNephronophthisisSenior-Loken Syndrome+3 more
Assistance Publique - Hôpitaux de Paris 240
Not applicableEnded earlyNCT00078091
What this trial is testing

Genetics and Clinical Characteristics of Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
National Human Genome Research Institute (NHGRI) 194
Not applicableLooking for participantsNCT02329210
What this trial is testing

Clinical Registry Investigating Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Marshfield Clinic Research Foundation 1,200
Not applicableStudy completedNCT07602803
What this trial is testing

The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UK

Who this might be right for
Bardet-Biedl Syndrome
The Queen Elizabeth Hospital 300
Not applicableApproved For MarketingNCT05183802
What this trial is testing

An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)

Who this might be right for
Bardet-Biedl Syndrome (BBS)Obesity
Rhythm Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT03746522
What this trial is testing

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Alström Syndrome (AS)
Rhythm Pharmaceuticals, Inc. 52
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Not applicableStudy completedNCT05400278
What this trial is testing

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Oslo University Hospital 30
Not applicableNot Yet RecruitingNCT06615011
What this trial is testing

Bardet Beidle Syndrome in a Syrian Adolescent : a Rare Case Report

Who this might be right for
Bardet Biedl Syndrome (BBS)
Al Baath University 100
Not applicableActive Not RecruitingNCT06239064
What this trial is testing

Early Genetic Identification of Obesity

Who this might be right for
Obesity, ChildhoodHyperphagiaRetinopathy+5 more
Rolfs Consulting und Verwaltungs-GmbH (RCV) 1,000
Large-scale testing (Phase 3)Study completedNCT04966741
What this trial is testing

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency ObesityPCSK1 Deficiency Obesity+1 more
Rhythm Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)WithdrawnNCT03490019
What this trial is testing

Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement

Who this might be right for
Bardet-Biedl SyndromeVisual Impairment
University Hospital Tuebingen
Large-scale testing (Phase 3)Study completedNCT05194124
What this trial is testing

Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency
Rhythm Pharmaceuticals, Inc. 19
Not applicableLooking for participantsNCT04463316
What this trial is testing

GROWing Up With Rare GENEtic Syndromes

Who this might be right for
Prader-Willi SyndromePWS-like SyndromeSilver Russel Syndrome+30 more
dr. Laura C. G. de Graaff-Herder 600
Not applicableStudy completedNCT00213811
What this trial is testing

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Who this might be right for
Bardet-Biedl SyndromeOrphan Diseases
University Hospital, Strasbourg, France 40
Not applicableLooking for participantsNCT01401998
What this trial is testing

ARPKD Database Study

Who this might be right for
Hepato/Renal Fibrocystic DiseaseAutosomal Recessive Polycystic Kidney DiseaseJoubert Syndrome+7 more
Children's Hospital of Philadelphia 200
Post-approval studies (Phase 4)Looking for participantsNCT07674290
What this trial is testing

Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Bardet Biedl SyndromeBardet-Biedl Syndrome (BBS)+1 more
Tom Hühne 200
Not applicableLooking for participantsNCT04461444
What this trial is testing

COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study

Who this might be right for
Bardet-Biedl SyndromeAlström Syndrome
University Hospital, Strasbourg, France 350